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Abstract
Background: The biomedical literature is a rich source of associative information but too vast for
complete manual review. We have developed an automated method of literature interrogation
called "Literature Lab" that identifies and ranks associations existing in the literature between gene
sets, such as those derived from microarray experiments, and curated sets of key terms (i.e.
pathway names, medical subject heading (MeSH) terms, etc).
Results:  Literature Lab was developed using differentially expressed gene sets from three
previously published cancer experiments and tested on a fourth, novel gene set. When applied to
the genesets from the published data including an in vitro experiment, an in vivo mouse experiment,
and an experiment with human tumor samples, Literature Lab correctly identified known biological
processes occurring within each experiment. When applied to a novel set of genes differentially
expressed between locally invasive and metastatic prostate cancer, Literature Lab identified a
strong association between the pathway term "FOSB" and genes with increased expression in
metastatic prostate cancer. Immunohistochemistry subsequently confirmed increased nuclear
FOSB staining in metastatic compared to locally invasive prostate cancers.
Conclusion: This work demonstrates that Literature Lab can discover key biological processes by
identifying meritorious associations between experimentally derived gene sets and key terms
within the biomedical literature.
Background
The accelerating expansion of biomedical research out-
paces most individual attempts at comprehensive review
even in relatively narrow fields. Just as the vast sequence
data available for the human [1,2] and additional organ-
isms [3-5] require sophisticated genomic browsing tools
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[6-8], computational methods are required to thoroughly
explore the corpus of biomedical literature. Many compu-
tational methods for interrogating the scientific literature
have been developed [9]. These programs can be broadly
defined as methods for information retrieval and those for
information extraction [10].
Existing methods can identify significant association
between individual genes and terms from the medical
subject heading (MeSH) index and Gene ontology (GO)
databases [11], manually curated biological lists [12], or
disease-specific lists [13]. These prior methods demon-
strate that genes with disease-specific differential expres-
sion can be strongly correlated with key terms within the
medical literature [13,14]. In addition, gene-gene associa-
tions within the literature have been combined with mul-
tiple available databases to extend associations beyond
the literature alone [15].
While these and similar approaches have underscored the
potential of automated literature searching to facilitate
discovery, few have provided both methods for assessing
the statistical strength of identified associations and sup-
ported their methods with experimental validation. Here,
we describe and apply "Literature Lab", a method of auto-
mated data retrieval confined to publicly available cita-
tions and abstracts. Literature Lab statistically assesses
identified associations within the corpus of medical liter-
ature between sets of experimentally derived genes and
key terms derived from curated or MeSH lists. We demon-
strate that our methodology can identify previously
reported relationships and can result in discovery.
Molecular Methods
Gene Expression Sets
Literature lab was applied to three gene sets derived from
previously published microarray data and one gene set
from as yet, unpublished dataset to determine if literature
mining identified important metabolic, physiologic, or
pathway activity. These gene sets include, 1) the top 100
genes with increased expression during in vitro exposure of
human leukemia cells (HL60, AML cell line) to ATRA
("UCT"), 2) the genes differentially regulated with a trans-
genic model of prostate neoplasia (MPAKT) following
exposure to RAD001, 3) the 70 genes used to predict out-
come in localized node-negative breast cancer, and 4)
genes differentially expressed between malignant epithe-
lial cells in local v. metastatic prostate cancers. The genes
lists are included in additional files and a full description
of the development of each gene set is in the supplemen-
tal methods (see Additional File 1).
Western Blots
Protein from fresh ventral prostates were extracted in RIPA
buffer [10 mM sodium phosphate (pH7.2) 150 mM NaCl,
1% Nonidet P-40, 0.1% SDS, 1 mM NaOVa, 1 mM DTT,
5 mM NaF, 0.1% sodium deoxycholate, 10 μg/ml leupep-
tin, 10 μg/ml aprotinin, and 1 mM PMSF] separated by gel
electrophoresis and transferred to nitrocellulose mem-
brane (0.45 μM) as described[16,17]. Membranes were
blotted with anti-Hif-1α (kindly provided by J. Pouysse-
gur) and anti-tubulin (B-5-1-2) (Sigma) (1:1000). Blots
were scanned and intensities were measured.
Immunohistochemistry
A prostate tissue microarray containing samples of benign
prostate epithelium (n = 14), locally invasive prostate ade-
nocarcinoma (n = 20), and metastatic prostate adenocar-
cinoma (n = 22) were stained for FOSB. The FOSB
staining was performed as previously described [18,19].
Briefly, 5 micrometer sections were cut from the TMA
block, deparaffinized, rehydrated and subjected to micro-
waving in 10-mM Citrate buffer (pH 6.00) in a 750W
oven, for 15 minutes. The polyclonal anti-FOSB primary
antibody (Santa Cruz Biotechnologies, Inc.), was incu-
bated (1:50 dilution) at room temperature in an auto-
mated stainer (Optimax Plus 2. 0; Biogenex, San Ramon,
CA). Antigen-antibody reaction was revealed with stand-
ardized development times, using the Streptavidin
method with 3, 3 diaminobenzidine as substrate. Meyer
Hematoxylin was used as nuclear counterstaining. FOSB
nuclear positivity was scored on a total of 50 nuclei per
sample. The statistical difference in FOSB staining
between the unpaired populations was assessed using a
two-tailed Mann Whitney test (GraphPad Prism4 Soft-
ware).
Application of Established Literature Mining Tools
MeSHer data for the gene lists was obtained from the web-
site [20] by supplying the Affymetrix U133Plus2 Ids corre-
sponding to the list of genes using a p-value threshold of
1.0 and no p-value correction.
GOMiner data for the gene lists was obtained by following
the instructions for downloading (build 148) and install-
ing the GOMiner application and SQL database from
[21]. A list of gene symbols for genes in the Affymetrix
U133Plus2 probe set list was used for the 'Total' file and
lists of symbols for the experimental genes used for the
'Changed' file. Other GOMiner settings used were the
default values defined in the GOMiner application.
Implementation
Overview
To highlight and prioritize cellular physiology, metabo-
lism, or pathways differentially active within a microarray
experiment, Literature Lab uses an experimentally derived
gene list, pre-defined sets of non-ambiguous key terms
("domains"), inclusive gene nomenclature, comprehen-
sive literature interrogation, and a comparison of theBMC Genomics 2007, 8:461 http://www.biomedcentral.com/1471-2164/8/461
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experimental gene set results with randomly generated
gene sets. For each experimentally derived gene set, Liter-
ature Lab performs an automated literature search to
determine the number of abstracts listing any of the iden-
tified genes and each term within the term list (or
domain). Specific domains include those for cell metabo-
lism (MeSH headings), cell physiology (MeSH headings),
and cellular pathways (manually curated from multiple
sources) (Additional File 2). Terms are ranked with a
measure of association between genes and terms known
as the product of frequency (PF) (see Additional File 1).
The strength of the relationship between an experimental
gene set and a term is determined by comparing the log
(base 10) of the sum of the PF values for the experimental
gene set (called the LPF) with a distribution of the same
values for 1000 random gene sets of the same size as the
experimental gene set. A score representing the number of
standard deviations above or below the mean value for
the random gene sets is assigned to each term and terms
are ranked in decreasing order of this score. To highlight
terms with particularly strong association with the gene
list, we developed heuristic rules for labeling the relation-
ships as "Strong" or "Moderate" (see Additional File 1 for
Details) (the software used for these analyses is free for
non-commercial use and available, see Availability and
Results section).
Overall Architecture of the Software Implementation
The software is implemented using Sun's Java program-
ming language [22] using the Eclipse software develop-
ment environment [23]. The software consists of three
major components:
• A series of programs which query PubMed for each term
and each gene in the Gene Thesaurus using NCBI's Entrez
Programming Utilities [24] and Sun's JAXB XML Binding
classes [25]. The result for each term or gene is a file con-
taining a list of the PubMed Ids for the term or gene. In
addition, summary files containing counts of the number
of abstracts for each gene and for each term are prepared.
￿ A series of programs which identify the PubMed Ids in
common for each term/gene combination from the lists
of ids for each term and each gene. The results of these
programs are files containing the PubMed Ids for each
term/gene combination and files containing summary
counts of the number of abstracts for each term/gene com-
bination.
￿ A series of programs for preparing the analysis of a spe-
cific gene list. These programs compute the described sta-
tistics for the gene list and for one thousand random gene
sets of the same size as the specific gene list being proc-
essed. The final step of this process prepares a Microsoft®
Excel spreadsheet containing the results of the analysis.
The Apache Software Foundation's POI classes (Java API
to Access Microsoft® Format Files [26] are used to format
the data in a form which can be viewed in Microsoft®
Excel.
Gene Annotation
Gene annotation began by obtaining gene names, sym-
bols, and "aliases" from Stanford University's SOURCE
web site [27]. Subsequent Boolean PubMed searches and
manual review for precision (i.e. the ability to accurately
identify abstracts related to the gene of interest) were used
to develop a set of rules required for more specific auto-
mated searching (Additional File 1). In subsequent litera-
ture searches, gene terms consisting entirely of numerals,
of three characters or less, or that were identified as exces-
sively ambiguous through manual review were excluded.
Algorithm-based disambiguation was not used [28].
While the database of gene terms (referred to as the gene
thesaurus) is frequently updated, for all experiments
herein described, the gene thesaurus updated last on 12/
30/2003 was used for all experiments presented (Addi-
tional File 3). 514 of the gene terms were specifically
excluded based upon the manual review (Additional File
4). All gene term curation was performed prior to testing
for associations.
Topic List Curation
Topic lists are sets of terms, each of which is to be tested
for significant associations with the experimentally
derived gene set. Topic lists used in the experiments were
defined using terms from the MeSH Thesaurus provided
by the National Library of Medicine. The list of terms for
each topic set consisted of all terms and all descendents
(with few exceptions) as listed in MeSH. The topic sets
(presented as "name [Mesh ID]") used in these experi-
ments were Cell Metabolism [G06.535] and Cell Physiol-
ogy [G04.335] (Additional File 2). A few of the
descendents of these MeSH terms were ignored because
very few abstracts were associated with the term. When
using MeSH terms to search PubMed, the search syntax
used "MeSH Subheading Explosion" so that the resulting
list of abstracts included abstracts coded with descendents
(if any) of the MeSH term as well as abstracts coded with
the MeSH term itself.
In addition, a topic set entitled "Pathways" was derived
using the pathway descriptions from BioCarta [29] with
some additional curation and testing (see Additional File
1 for methods and Additional File 2 for list of pathways).
All pathway term curation was performed prior to testing
for associations.
Literature Search
A list of the PubMed abstract ID's for each gene and each
topic were obtained by searching PubMed using theBMC Genomics 2007, 8:461 http://www.biomedcentral.com/1471-2164/8/461
Page 4 of 14
(page number not for citation purposes)
appropriate terms and a constant date range. The PubMed
Electronic Date (EDAT) was used to query a constant sub-
set of the PubMed abstracts between 12/31/93 and 12/31/
03. Whole text information was not used due to its incom-
plete and inconsistent availability. To determine if results
changed over time with a fixed chronological time frame
and pre-set search parameters, three gene lists ("Ideal",
"UCT", and "Van't Veer") and three curated term lists
(metabolism, physiology, pathway) were run repetitively
every month for 5 months using the fixed dates above in
order to assess if ongoing efforts at the NCBI to improve
the search engine or annotation of the literature signifi-
cantly influence our approach to literature mining.
Term Ranking
Each topic list was analyzed independently. Within each
topic set, specific terms were ranked according to how
many times the term was associated with any of the genes
in the gene list with respect to the total number of times
the term is present in PubMed. We applied two different
methods to measure the degree of intersection between
any term and the gene set. First, we calculated the ratio of
the number of abstracts containing any gene from the
gene list AND the term divided by all abstracts containing
the term (referred to as "expected abstracts"). The second
score (called "product of frequency") takes into account
the number of abstract mentions against the entire target
gene set (see Additional File 1). In order to rank terms, we
compared each terms score (by either method) to a distri-
bution of scores between the same term and randomly
selected gene sets. In the case of the product of frequency,
the log(PF) (LPF) more closely approximated a normal
distribution thus justifying the mean and standard devia-
tion statistics used (see Additional File 1).
Testing against random gene sets
In order to provide a metric by which to interpret the rank-
ings and determine the likelihood of finding a match
given no association, we measure each topic score given
the experimental set of genes against the distribution of
scores from sets of genes chosen at random. Scoring 1,000
such random sets against the topic set, we obtain esti-
mates for the mean and standard deviation of the F(gene-
set, topic) score for each topic. We tested if there was a
significant difference in the statistics generated using or
1000 random sets of genes containing the same number
of genes as the experimental gene set.
Results
We applied Literature Lab to lists of genes generated
through microarray experiments to determine if such an
approach provides biological insight. We started with 3
lists of genes from previously published microarray exper-
iments, one generated in vitro (HL60 cells treated with
ATRA [30], one generated in vivo (MPAKT transgenic mice
treated with RAD001 [17]), and one generated from
human tumors samples (A 70 gene model of breast recur-
rence [31,32]) to see if Literature Lab would correctly
identify known biological processes and to how altering
specific variables within Literature Lab impacts the results.
Finally, we tested our method to a set of genes differen-
tially expressed between local and metastatic prostate
tumors and used immunohistochemistry to confirm the
lead candidate.
Literature Lab associates "respiratory burst" with ATRA 
treatment of a leukaemia cell line
Acute promyeloblastic leukemia (APML) cells differenti-
ate when stimulated with all-trans retinoic acid (ATRA), a
life-saving treatment for this disease [33]. The physiologi-
cal impact of ATRA is detected by an increase in nitro blue
tetrazolium (NBT) reduction (Fig. 1D), an assay estab-
lished to measure the production of oxygen intermediates
associated with respiratory bursts in cells [34]. We used
microarray data available from a recent publication [30]
to identify the top genes with increased expression in
HL60 cells (a cell line used to model APML) following
ATRA exposure (Fig. 1A and 1B). Genes with increased
expression were analyzed with Literature Lab using key
term sets for cellular metabolism, physiology, and path-
ways. Within the top ranked key terms for both metabo-
lism and physiology was "respiratory burst" (Fig. 1C).
This observation is confirmed by an increase in nitro blue
tetrazolium (NBT) reduction, an established measure of
the production of oxygen intermediates associated with
respiratory bursts in cells [34].
We tested the impact of gene set size and literature time
frame on the successful association between "respiratory
burst" and the genes with increased expression following
ATRA. While the specific literature time frame had rela-
tively little impact on the association (i.e. first or last 5
years of the 10 year period) (see Additional File 5), the
number of differentially expressed genes included in the
analysis did impact our results (see Additional File 6) Spe-
cifically, the association between "respiratory burst" and
the experimentally derived list of differentially expressed
genes did not stabilize until greater than 150 genes were
included. While there are no obvious rules to guide the
upper limit with respect to the number of genes to be used
in literature lab, the variability of results observed with
shorter gene lists suggests that gene lists numbering less
than 25 will not provide robust results and for experi-
ments comparing phenotypes with marked differences,
gene lists greater than 150 are encouraged.
"Hif and Hypoxia" strongly associated with mTOR 
inhibition
To test Literature Lab on a more challenging, in vivo
derived dataset, we applied Literature Lab to a set of genesBMC Genomics 2007, 8:461 http://www.biomedcentral.com/1471-2164/8/461
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HL60 Leukemia cells treated with ATRA Figure 1
HL60 Leukemia cells treated with ATRA. A) May Grunwald Giemsa stain of HL60 cells prior to (upper) and following 
treatment with ATRA (lower). B) Heat map of the top 100 genes with increased expression in HL60 cells treated with ATRA 
compared to untreated HL60 cells (Red – high normalized expression, Blue – low normalized expression). C) Percentage of 
cells positive for nitro blue tetrazolium (NBT) reduction (Mean +/- St dev). D) Literature Lab ranking, association scores, and 
confidence calls for cell physiology, metabolism, and pathway terms (Association score is the log of the product of frequency 
(logPF)).BMC Genomics 2007, 8:461 http://www.biomedcentral.com/1471-2164/8/461
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whose expression increased with the prostate-specific
expression of myristoylated AKT (also associated with the
eventual prostate phenotype of prostatic intraepithelial
neoplasm) and decreased when mice were treated with
RAD001, an mTOR inhibitor (Fig. 2A). This experiment
was well controlled, characterized in a published manu-
script [17], and has publicly available data (Gene Expres-
sion Omnibus accession number GSE1413). We
performed a 10-year literature query to identify pathway
terms associated with the 64 genes previously found to
have the expression pattern described above [17]. Litera-
ture Lab identified "Hif" and "Hypoxia" terms in associa-
tion with the list of genes thus highlighting the key
biological insight discussed in the primary report (Fig.
2B). While HIF gene expression (HIF1A and HIF3A) was
part of the original gene list and contributed to the strong
association, Literature Lab found 12 and 17 additional
genes associated with the key terms "Hif" and "Hypoxia",
respectively, thus elevating these terms above others. Sub-
sequent Western blotting for protein expression of Hif1α
further supports the identified association (Fig. 2C) and
demonstrates Literature Labs potential utility for data
derived from animal models.
"Matrix metalloproteinase 9" and "VEGF" are associated 
with Breast Cancer Prognosis
Primary tumors perhaps provide the biggest challenge for
analysis because of the additional associated technical
and biological variation. We applied Literature Lab to the
set of 70 genes associated with outcome in two seminal
papers predicting breast cancer recurrence using microar-
ray data [31,32]. Interestingly, of the cellular pathways
investigated, "matrix metalloproteinase" and "VEGF"
were strongly associated with the gene set (see Additional
File 7). This unbiased association is strongly supported by
prior studies finding MMP [35,36] and VEGF [37] activity
strongly associated with the recurrent phenotype [37] and
supports Literature Lab's applicability to data from
human samples.
Literature drift
Given the daily growth of biomedical literature, reproduc-
ible literature search results require investigators to desig-
nate a specific chronological interval within which they
queried for associations between a gene list and key terms.
However, repeated queries using identical search criteria
within a fixed interval demonstrated some lability hereto
forward referred to as "literature drift". In sequential runs
over 5 months, we measured this drift using the absolute
value of the percentage change in the LPF value. Literature
drift resulted in a median difference between queries of
2.51%. This degree and rate of literature drift was depend-
ent both on the gene list and key terms as three independ-
ent sets of genes queried for three sets of key terms
experienced different degrees of drift (Table 1).
By identifying the abstracts lost or gained between
sequential runs, we identified a number of causal factors
for literature drift:
￿ Changes to the various components of the NCBI search
engine that result in different results for the same query.
In particular, changes to the PubMed "phrase dictionary"
are frequent and can yield different results for the same
query at different points in time.
￿ The assignment of MeSH terms to abstracts subsequent
to the addition of abstracts to the PubMed database.
￿ The editing of PubMed abstracts so as to change the title
or text.
￿ The occasional deletion of abstracts from the database.
Many of these deletions appear to be the removal of dupli-
cates added to the PubMed database in error.
Importantly, while literature drift affected the numbers of
abstracts linking a gene list with a term list, it had only
minor effects on the final results of Literature Lab (Fig. 3).
In addition, when the effects of literature drift were ana-
lyzed according to the strength of association between a
key term and a set of genes; stronger associations were less
likely to change when compared to associations with
modest or no weight (11% for Strong (1 of 9), 16% for
Moderate (5/32), and 27% for associations without
weight (13 of 49). Thus while literature drift impacts the
number of associations identified between the medial lit-
erature and a set of genes, our methodology minimizes its
impact.
Discovery of increased FOSB in Metastatic Prostate 
Cancer
While the Literature Lab results from the HL60 cell line,
MPAKT mouse, and breast cancer tumors are compelling,
these sets had known biological associations and were
used to help evaluate the methods herein described; they
cannot be viewed as independent tests of our method. In
order to test Literature Lab's ability to identify valid gene-
key term associations through automated literature inter-
rogation, we applied literature lab to microarray data
obtained after RNA amplification of local and metastatic
prostate cancer specimens. We first identified the top 100
genes up-regulated in the metastatic samples in order to
identify the top pathway(s) associated with metastasis.
FOSB was the top pathway and the only pathway term
meeting heuristic criteria for a "strong" association (Fig.
4A). Expression of the FOSB gene was associated with
metastasis but the additional identification of associa-
tions between FOSB and 5 other genes having increased
expression in the metastatic tumors resulted in the top
ranking of FOSB and a "strong" heuristic label. Based onBMC Genomics 2007, 8:461 http://www.biomedcentral.com/1471-2164/8/461
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MPAKT mouse treated with RAD001 Figure 2
MPAKT mouse treated with RAD001. A) Heat map of normalized gene expression for the top 64 genes correlating with 
AKT expression and RAD001 treatment in the prostates of transgenic MPAKT mice. B) Association of pathway terms 
(Squares) with the 64 genes (circles) associated with RAD001 treatment of MPAKT mice. Size of square indicates confidence 
of associations, thickness of connecting line correlates with the number of abstracts linking any pair of term and gene. C) Pro-
tein lysates prepared from the VP of individual MPAKT and WT mice either treated with RAD001 (+) or with placebo (-) for 
48 hours were immunoblotted with anti-Hif1α and anti-tubulin as indicated. Lower panel shows the densitometric ratio of 
Hif1α and tubulin.BMC Genomics 2007, 8:461 http://www.biomedcentral.com/1471-2164/8/461
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this result, we performed FOSB immunohistochemistry
on a tissue microarray containing benign, local malig-
nant, and metastatic malignant prostate tissue. Nuclear
FOSB was significantly increased in the metastatic tumors
compared to the locally invasive tumors (p = 0.0013, two-
tailed Mann Whitney test) thus confirming the associa-
tion highlighted by Literature Lab (Fig. 4B and Fig 4C).
Comparison with GOMiner, MESHER and GeneCite
To determine how Literature Lab compares with existing,
publicly available sample annotation and literature min-
ing technologies, we imported the AKT mouse and meta-
static prostate cancer gene lists into GOMiner [21],
MeSHer [20], and GeneCite [38]. When the AKT mouse
gene set was imported into GOMiner, 222 GO terms were
found to be significantly associated (p ≤ 0.05) with the
genes differentially expressed (see Additional File 8).
Among the significant GO terms were "response to
hypoxia" and "glycolysis" thus demonstrating that GOM-
iner is able to identify similar underlying biology but
these terms were among a large number of significant
terms and not prominent. Here we note that GOMiner
and Literature Lab represent different approaches (enrich-
ment analysis v. Literature mining, respectively) and, as
such, the results are not directly comparable. However,
the purposes of Literature Lab and GOMiner are similar
(i.e. the identification of biological processes implicated
by differential gene expression) and our results suggest
Table 1: Median of Absolute Value of Percentage Change in LPF 
over 5 Months
Metabolism 
Terms
Physiology 
Terms
Pathways 
Terms
MPAKT Gene Set 1.90% 1.98% 3.09%
HL60 Gene Set 1.32% 3.08% 3.41%
vant Veer Gene Set 1.05% 2.22% 1.91%
Literature Drift Figure 3
Literature Drift. Literature Lab results for repeat analysis performed on data from HL60 cells, MPAKT mice, and Breast 
Cancer tumors. The ranking of the top 10 terms from the Metabolism, Physiology, and Pathway lists are presented when the 
same analysis was performed within fixed dates (12/31/93 and 12/31/03). The ranking of each term is followed across the 5 
monthly repeats by connecting lines. Color of line indicates strength of association (red = "strong"; tan = "moderate", white = 
no call).BMC Genomics 2007, 8:461 http://www.biomedcentral.com/1471-2164/8/461
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FOSB Identification and Immunohistochemistry Figure 4
FOSB Identification and Immunohistochemistry. A) Ranking, association scores, and confidence calls for pathway terms 
associated with the 100 genes with increased expression in metastatic prostate tumors compared to local prostate tumors 
(Association score is the log of the product of frequency (logPF)). B) Two examples of local (left) and metastatic (right) pros-
tate cancer FOSB expression measured by immunohistochemistry. C) Percentage of epithelial cell nuclei staining positive for 
benign prostate epithelium (n = 14), local prostate cancer (n = 20), and metastatic prostate cancer (n = 22) (* Met v. Local, p = 
0.0013).BMC Genomics 2007, 8:461 http://www.biomedcentral.com/1471-2164/8/461
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that direct literature mining and our statistical approach
provide insight that cannot be fully reproduced using
GOMiner.
MESHER did not find a significant association between
"Hypoxia", "HIF", and "Hypoxia p53" and the AKT mouse
gene list and there was very poor comparison between
MESHER and Literature Lab despite each method using
MeSH terms (see Additional File 9). GeneCite identifies
the abstracts associating the terms and genes but has no
direct measure of significance other than the number of
abstracts (which favours more general terms over more
specific terms). In addition, GeneCite has lower precision
and recall when compared to Literature Lab due to the
lack of a thesaurus for gene nomenclature (see Additional
File 10). For example, many of the abstracts for the CAT
gene refer to felines and CAT scans and not to the CAT
gene.
When the genes differentially expressed between local and
metastatic prostate cancers were imported into GOMiner
and MESHER, there was poor overlap with both. FOSB,
the term significantly associated with metastatic prostate
cancer and subsequently validated by immunohistochem-
istry, was either not present in the library (GOMiner) or
not associated with the gene list (MESHER, "Biogenetics-
MeSH – "Genes, fos"). Results for GeneCite (see Addi-
tional File 11) exhibit the same limitations previously
described for the AKT mouse gene set.
Discussion
Full utilization of publicly available, data-rich resources
remains a universal challenge in contemporary scientific
investigation. As technologies have diminished the cost
and time associated with data collection, content within
diverse repositories of data have increased exponentially.
The medical literature is one such data repository and a
repository that continues to grow rapidly. While investiga-
tors frequently use computational tools to interrogate
genomic or gene expression data repositories, few use sim-
ilar tools when reviewing the literature.
Literature Lab represents a method to comprehensively
interrogate the literature for associations between a list of
genes and a list of key terms in an unbiased manner in
order to highlight potentially important biological proc-
esses implicated by the gene list. While there are many
methods by which to develop a gene list, we have
designed Literature Lab to aid in the analysis of microar-
ray experiments which frequently associate the expression
of hundreds to thousands of seemingly unrelated genes
with cellular behaviors, in vivo phenotypes, or disease
outcomes. We developed and refined our methodology
using gene sets from previously published work and suc-
cessfully tested Literature Lab on a novel dataset. The
pathway term FOSB was ranked highest by Literature Lab
and highlighted as having a "strong" association; an
increase in nuclear FOSB staining was subsequently con-
firmed with immunohistochemistry.
Literature Lab is complementary to the increasingly prev-
alent pathway oriented approaches to the analysis of
microarray data (Reviewed in [39]). As a general
approach, these methods look for significant differential
expression within a microarray experiment using pre-
determined aggregations of genes (alternatively called
gene sets, metagenes, or gene modules) rather than indi-
vidual genes [40]. Successful gene sets can identify under-
lying genetic abnormalities or signal transduction
networks driving disease pathologies and help effectively
bridge microarray data with biological significance
[41,42].
Some pathway approaches methods use the literature and
publicly available annotations (Gene Ontology) to
develop gene sets and use these gene sets to interrogate
expression data [43,44]. Literature Lab offers the opportu-
nity to use a gene set derived from microarray data to
interrogate the biomedical literature without a priori clas-
sification or annotation. As such, Literature Lab can
appropriately interrogate the literature as it grows and
evolves. When compared to two publicly available meth-
ods of analysis (GOMiner and MeSHer), the results of Lit-
erature Lab were more comparable with GOMiner.
However, the statistical evaluation of associations identi-
fied by Literature Lab help improve the specificity of find-
ings (highlighting strong associations) while maintaining
sensitivity (neither GOMiner nor MeSHer identified the
association between FOSB and genes with differential
expression between local and metastatic prostate cancer).
It should be noted, however, that given the difference in
the approaches, our results cannot be interpreted as dem-
onstrating the superiority of Literature Lab over GOMiner
Literature Lab remains dependent on the strength of the
term lists and while we have demonstrated the use of lists
for metabolism, physiology, and pathways, further devel-
opment is focused on creating lists to include disease,
pharmacological agents, drug toxicities, and many addi-
tional classes.
We initially anticipated that fixing the chronological inter-
val for a query would ensure exact reproduction of the
results. However, we identified literature drift within fixed
retrospective intervals. While the degree of literature drift
seems to range from minimal to moderate depending on
the specific gene list, Literature Lab successfully limits the
effects of literature drift especially for associations identi-
fied as "strong" with the current heuristics. Thus, while lit-
erature drift is unlikely to have significant impact on theBMC Genomics 2007, 8:461 http://www.biomedcentral.com/1471-2164/8/461
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associations identified by Literature Lab, some variation
in the specific weights and rankings of associations will
change even when investigators define a fixed chronolog-
ical interval within which they perform their query.
For this initial description, we focused on developing a
robust measure of association, a relatively useful measure
of significance, and heuristic rules to highlight the most
important associations. Clearly, the specifics of our meth-
ods will be the subject of further investigation and refine-
ment. While we have identified some critical elements of
success (avoiding measures of association that are driven
by single gene-term associations and having a gene set size
of 25 or more), work is ongoing to explore the effects of
refining the genes based upon the statistical association
between their expression and the phenotype, limiting Lit-
erature Lab to specific journals of high quality content,
and increasing the number of sets of key terms with which
to test the association between gene expression.
Conclusion
The methodology herein described for Literature Lab
highlights the biomedical literature as a content-rich
resource amenable to automated, comprehensive interro-
gation. As with most complex data, successful compre-
hensive interrogation requires filtering out the noise and
finding valuable information. Our current methods of
gene annotation, key term curation, and literature interro-
gation, can find strong associations and are likely to ben-
efit a diverse scientific community.
Availability and Requirement
The instructions, software, and data required to perform
an analysis of a gene list using the techniques described
herein can be obtained from http://www.acumenta.com/
freeware/instructions.html. Sun's Java Runtime environ-
ment Version 1.4 or higher is required in order to run the
software (and may be downloaded from [22]). The soft-
ware runs on both Windows platforms (Windows 2000
and later) and Linux platforms. Memory of 1 GB and 5 GB
of available disk space are required (much of the disk
space requirement is for temporary storage during the
analysis). In addition, the results of the analysis are pre-
sented in a Microsoft Excel spreadsheet for viewing on any
system having a spreadsheet viewer capable of rendering
the Microsoft Excel format.
￿ Project name: Literature Lab
￿  Project home page: http://www.acumenta.com/free
ware/instructions.html
￿ Operating system(s): Windows (2000 +) or Linux
￿ Programming language: e.g. Java
￿ Other requirements: Java Runtime environment 1.4 or
higher
￿ License: Not required for Academic users
￿  Any restrictions to use by non-academics: License
needed from Acumenta
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